Material and Methods:
The authors talk about natural infection-clinical mastitis without clarifying which was the causing agent. Did they perform microbiological analysis to identify the responsible pathogen? Was the responsible pathogen the same for all three cases? Line 22: The current reference genome version is Ovis aries v3.1. The authors mention that they are using Oar_v4.0 genomic dataset. Could the authors give some more details on these? Line 36: I assume that the P <0.05 is the uncorrected P value and not the adjusted after FDR correction. I am wondering how many genes remain significantly differentially expressed after adjusting for multiple testing using FDR correction. A P <0.05 is a very mild threshold and the results could be false positive. This should be amended and the genes which are presented as differentially expressed should be the ones which remain significant after correcting for multiple testing. Did you find in the two groups any differentially spliced genes?
Decision letter (RSOS-181604.R0)
26-Mar-2019
Dear Dr Li,
The editors assigned to your paper ("Digital gene expression analyses of mammary glands from meat ewes naturally infected with clinical mastitis") have now received comments from reviewers.
While one reviewer is positive about publication of your paper, the other reviewer raises some substantive comments on significance thresholds and the analysis of expression data. It will be important to address carefully these comments in your revision.
We would like you to revise your paper in accordance with the referee's suggestions which can be found below (not including confidential reports to the Editor). Please note this decision does not guarantee eventual acceptance.
Please submit a copy of your revised paper before 18-Apr-2019. Please note that the revision deadline will expire at 00.00am on this date. If we do not hear from you within this time then it will be assumed that the paper has been withdrawn. In exceptional circumstances, extensions may be possible if agreed with the Editorial Office in advance. We do not allow multiple rounds of revision so we urge you to make every effort to fully address all of the comments at this stage. If deemed necessary by the Editors, your manuscript will be sent back to one or more of the original reviewers for assessment. If the original reviewers are not available, we may invite new reviewers.
To revise your manuscript, log into http://mc.manuscriptcentral.com/rsos and enter your Author Centre, where you will find your manuscript title listed under "Manuscripts with Decisions." Under "Actions," click on "Create a Revision." Your manuscript number has been appended to denote a revision. Revise your manuscript and upload a new version through your Author Centre.
When submitting your revised manuscript, you must respond to the comments made by the referees and upload a file "Response to Referees" in "Section 6 -File Upload". Please use this to document how you have responded to the comments, and the adjustments you have made. In order to expedite the processing of the revised manuscript, please be as specific as possible in your response.
In addition to addressing all of the reviewers' and editor's comments please also ensure that your revised manuscript contains the following sections as appropriate before the reference list:
• Ethics statement (if applicable) If your study uses humans or animals please include details of the ethical approval received, including the name of the committee that granted approval. For human studies please also detail whether informed consent was obtained. For field studies on animals please include details of all permissions, licences and/or approvals granted to carry out the fieldwork.
• Data accessibility It is a condition of publication that all supporting data are made available either as supplementary information or preferably in a suitable permanent repository. The data accessibility section should state where the article's supporting data can be accessed. This section should also include details, where possible of where to access other relevant research materials such as statistical tools, protocols, software etc can be accessed. If the data have been deposited in an external repository this section should list the database, accession number and link to the DOI for all data from the article that have been made publicly available. Data sets that have been deposited in an external repository and have a DOI should also be appropriately cited in the manuscript and included in the reference list.
If you wish to submit your supporting data or code to Dryad (http://datadryad.org/), or modify your current submission to dryad, please use the following link: http://datadryad.org/submit?journalID=RSOS&manu=RSOS-181604
• Competing interests Please declare any financial or non-financial competing interests, or state that you have no competing interests.
• Authors' contributions All submissions, other than those with a single author, must include an Authors' Contributions section which individually lists the specific contribution of each author. The list of Authors should meet all of the following criteria; 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published.
All contributors who do not meet all of these criteria should be included in the acknowledgements.
We suggest the following format: AB carried out the molecular lab work, participated in data analysis, carried out sequence alignments, participated in the design of the study and drafted the manuscript; CD carried out the statistical analyses; EF collected field data; GH conceived of the study, designed the study, coordinated the study and helped draft the manuscript. All authors gave final approval for publication.
• Acknowledgements Please acknowledge anyone who contributed to the study but did not meet the authorship criteria.
• Comments to the Author(s) The manuscript describes transcriptomic changes in mammary glands of sheep affected with clinical mastitis compared to healthy mammary tissues. The study resulted in the typical long list of DEGs, that were subsequently grouped into a meaningful functional categorization. Validation of RNA-seq results was done for a few genes with RT-qPCR and immunohistochemistry. The study was well-conducted and as transcriptome data of clinical mastitis in sheep are yet not available it represents an important addition to literature.
Reviewer: 2
Comments to the Author(s) This is an interesting manuscript studying the transcriptome signature of clinical mastitis in sheep. Although the manuscript is well written, the sample size is small and the authors used very mild significant thresholds. Stricter significant thresholds-at least adjusting for multiple testing-should be performed for the Differential Expression analysis. All the analysis related to co-expression, pathway and network analysis etc should be repeated using only the DE results after adjusting for multiple testing using for example FDR correction. Moreover, the whole discussion should be re-written in a more focused way with in depth comparisons among the present studies and previous studies on the topic. The authors also miss recent publications on the topic for example https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-3982-1 Material and Methods:
The authors talk about natural infection-clinical mastitis without clarifying which was the causing agent. Did they perform microbiological analysis to identify the responsible pathogen? Was the responsible pathogen the same for all three cases? Line 22: The current reference genome version is Ovis aries v3.1. The authors mention that they are using Oar_v4.0 genomic dataset. Could the authors give some more details on these? Line 36: I assume that the P <0.05 is the uncorrected P value and not the adjusted after FDR correction. I am wondering how many genes remain significantly differentially expressed after adjusting for multiple testing using FDR correction.
A P <0.05 is a very mild threshold and the results could be false positive. This should be amended and the genes which are presented as differentially expressed should be the ones which remain significant after correcting for multiple testing. Did you find in the two groups any differentially spliced genes?
Author's Response to Decision Letter for (RSOS-181604.R0) See Appendix A.
RSOS-181604.R1 (Revision)
Review form: Reviewer 2
Is the manuscript scientifically sound in its present form? Yes

Are the interpretations and conclusions justified by the results? Yes
Is the language acceptable? Yes
Is it clear how to access all supporting data? Yes
Do you have any ethical concerns with this paper? No
Have you any concerns about statistical analyses in this paper? No
Recommendation?
Accept with minor revision (please list in comments)
Comments to the Author(s)
The authors have done a good job addressing previous comments and revising the manuscript accordingly. I am happy with the current version of the manuscript. My only concern is the English writing of the manuscript which needs some further improvement.
Minor comments below: Line 15 page 2 Introduction: is this indigenous sheep breed meat or dairy? Line 52 page 2 M&M: change the "is both caused" with "were both caused" Page 8 line 48 discussion: change "compare with" to "compare to" Page 8 line 57 discussion: change "in accord" with "in accordance" Page 9 lines 53-55: the sentence should be re-written to make better sense.
Decision letter (RSOS-181604.R1)
30-May-2019
Dear Dr Li:
On behalf of the Editors, I am pleased to inform you that your Manuscript RSOS-181604.R1 entitled "Digital gene expression analyses of mammary glands from meat ewes naturally infected with clinical mastitis" has been accepted for publication in Royal Society Open Science subject to minor revision in accordance with the referee suggestions. Please find the referees' comments at the end of this email.
The reviewers and Subject Editor have recommended publication, but also suggest some minor revisions to your manuscript. Therefore, I invite you to respond to the comments and revise your manuscript.
• Ethics statement If your study uses humans or animals please include details of the ethical approval received, including the name of the committee that granted approval. For human studies please also detail whether informed consent was obtained. For field studies on animals please include details of all permissions, licences and/or approvals granted to carry out the fieldwork.
• Data accessibility It is a condition of publication that all supporting data are made available either as supplementary information or preferably in a suitable permanent repository. The data accessibility section should state where the article's supporting data can be accessed. This section should also include details, where possible of where to access other relevant research materials such as statistical tools, protocols, software etc can be accessed. If the data has been deposited in an external repository this section should list the database, accession number and link to the DOI for all data from the article that has been made publicly available. Data sets that have been deposited in an external repository and have a DOI should also be appropriately cited in the manuscript and included in the reference list.
If you wish to submit your supporting data or code to Dryad (http://datadryad.org/), or modify your current submission to dryad, please use the following link: http://datadryad.org/submit?journalID=RSOS&manu=RSOS-181604.R1
• Funding statement Please list the source of funding for each author.
Please note that we cannot publish your manuscript without these end statements included. We have included a screenshot example of the end statements for reference. If you feel that a given heading is not relevant to your paper, please nevertheless include the heading and explicitly state that it is not relevant to your work.
Because the schedule for publication is very tight, it is a condition of publication that you submit the revised version of your manuscript before 08-Jun-2019. Please note that the revision deadline will expire at 00.00am on this date. If you do not think you will be able to meet this date please let me know immediately.
To revise your manuscript, log into https://mc.manuscriptcentral.com/rsos and enter your Author Centre, where you will find your manuscript title listed under "Manuscripts with Decisions". Under "Actions," click on "Create a Revision." You will be unable to make your revisions on the originally submitted version of the manuscript. Instead, revise your manuscript and upload a new version through your Author Centre.
When submitting your revised manuscript, you will be able to respond to the comments made by the referees and upload a file "Response to Referees" in "Section 6 -File Upload". You can use this to document any changes you make to the original manuscript. In order to expedite the processing of the revised manuscript, please be as specific as possible in your response to the referees.
When uploading your revised files please make sure that you have: 1) A text file of the manuscript (tex, txt, rtf, docx or doc), references, tables (including captions) and figure captions. Do not upload a PDF as your "Main Document". 2) A separate electronic file of each figure (EPS or print-quality PDF preferred (either format should be produced directly from original creation package), or original software format) 3) Included a 100 word media summary of your paper when requested at submission. Please ensure you have entered correct contact details (email, institution and telephone) in your user account 4) Included the raw data to support the claims made in your paper. You can either include your data as electronic supplementary material or upload to a repository and include the relevant doi within your manuscript 5) All supplementary materials accompanying an accepted article will be treated as in their final form. Note that the Royal Society will neither edit nor typeset supplementary material and it will be hosted as provided. Please ensure that the supplementary material includes the paper details where possible (authors, article title, journal name).
Supplementary files will be published alongside the paper on the journal website and posted on the online figshare repository (https://figshare.com). The heading and legend provided for each supplementary file during the submission process will be used to create the figshare page, so please ensure these are accurate and informative so that your files can be found in searches. Files on figshare will be made available approximately one week before the accompanying article so that the supplementary material can be attributed a unique DOI.
Once again, thank you for submitting your manuscript to Royal Society Open Science and I look forward to receiving your revision. If you have any questions at all, please do not hesitate to get in touch. Comments to the Author(s) The authors have done a good job addressing previous comments and revising the manuscript accordingly. I am happy with the current version of the manuscript. My only concern is the English writing of the manuscript which needs some further improvement.
Comments from the Editorial Office:
For information about language editing services endorsed by the Royal Society, please follow the link below: https://royalsociety.org/journals/authors/language-polishing/ Author's Response to Decision Letter for (RSOS-181604.R1)
Decision letter (RSOS-181604.R2)
04-Jun-2019
Dear Dr Li, I am pleased to inform you that your manuscript entitled "Digital gene expression analyses of mammary glands from meat ewes naturally infected with clinical mastitis" is now accepted for publication in Royal Society Open Science.
You can expect to receive a proof of your article in the near future. Please contact the editorial office (openscience_proofs@royalsociety.org and openscience@royalsociety.org) to let us know if you are likely to be away from e-mail contact. Due to rapid publication and an extremely tight schedule, if comments are not received, your paper may experience a delay in publication.
Royal Society Open Science operates under a continuous publication model (http://bit.ly/cpFAQ). Your article will be published straight into the next open issue and this will be the final version of the paper. As such, it can be cited immediately by other researchers. As the issue version of your paper will be the only version to be published I would advise you to check your proofs thoroughly as changes cannot be made once the paper is published.
On behalf of the Editors of Royal Society Open Science, we look forward to your continued contributions to the Journal. 
Response to Reviewer 2 Comments
Point 1: This is an interesting manuscript studying the transcriptome signature of clinical mastitis in sheep. Although the manuscript is well written, the sample size is small and the authors used very mild significant thresholds. Stricter significant thresholds-at least adjusting for multiple testing-should be performed for the Differential Expression analysis. All the analysis related to co-expression, pathway and network analysis etc should be repeated using only the DE results after adjusting for multiple testing using for example FDR correction.
Response 1: Thank you very much for your comments. Admittedly, in the present study, the sample size is small, but it meets the minimum biological research requirement. In many relevant literatures published recently, the sample size is also n=3. In our ongoing study, we selected more sample size (n=5) to reveal the specific regulator mechanisms of key candidate genes and pathways in mastitic sheep mammary glands experimentally infected with single or mixed bacteria isolated from infected animals used in this study.
According to your comment, we re-screen the differentially expressed genes in healthy and mastitic groups based on thresholds of |log2(fold change)| > 1 and FDR < 0.05. All results related to clustering heatmap, GO annotation, pathway enrichment, co-expression network, protein-protein interaction network etc were also re-analyzed according to differential gene results after FDR correction.
Point 2:
The whole discussion should be re-written in a more focused way with in depth comparisons among the present studies and previous studies on the topic. The authors also miss recent publications on the topic for example https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-017-3982-1
Response 2: Thank you very much for your comment and suggestion. We have re-written the whole "Discussion" in our revised version according to the comment. In revised manuscript, we also cited this recent reference in "Discussion" part. Response 4: Thank you very much for your comment. We are very sorry for our negligence. In our revised manuscript, we have provided the URL address on Oar_v4.0 genomic dataset used in this study. For details, please see "3.3. Quality control of raw data and mapping reads to the genome" section.
Point 5: Line 36: I assume that the P < 0.05 is the uncorrected P value and not the adjusted after FDR correction. I am wondering how many genes remain significantly differentially expressed after adjusting for multiple testing using FDR correction. A P < 0.05 is a very mild threshold and the results could be false positive. This should be amended and the genes which are presented as differentially expressed should be the ones which remain significant after correcting for multiple testing.
